Optimization of Novel DCE-MRI Imaging Sequences for Cancer Therapy Monitoring

NCT01752231 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2017-12-21

No results posted yet for this study

Summary

This pilot clinical trial studies dynamic contrast enhanced (DCE)-magnetic resonance imaging (MRI) in diagnosing cancer. New diagnostic procedures, such as DCE-MRI may help find and diagnose cancer

Conditions

  • Normal Volunteers

Sponsors & Collaborators

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Jinha Park, MD, Ph.D. · City of Hope Medical Center

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-23
Primary Completion
2017-08-29
Completion
2017-08-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01752231 on ClinicalTrials.gov